Search for: "SCHERING-PLOUGH" Results 101 - 120 of 404
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Aug 2011, 7:13 am by Jeffrey Carton
  From 2004 to 2009, the drugs were marketed by Schering-Plough, which Merck subsequently acquired. [read post]
3 Aug 2011, 5:11 am by Lawrence B. Ebert
In the Pipeline suggests Merck's discovery research might move out of Rahway and to the former Schering-Plough site in Kenilworth. [read post]
7 Jul 2011, 9:02 pm by Paul Caron
, 132 Tax Notes 77 (July 5, 2011): Jackel reviews the recent Third Circuit Schering-Plough decision and attempts to determine whether the court’s express refusal to address the lower court’s economic substance analysis provides any guidance... [read post]
1 Jul 2011, 8:23 am by randal shaheen
Schering-Plough, the plaintiff, and manufacturer of Coppertone sunscreen, brought claims for false advertising against Neutrogena. [read post]
22 Jun 2011, 7:09 am by Peter Rost
BIOGRAPHY AND CV CONTACT INFORMATION CLIENT LISTEXPERT WITNESS SERVICESMEDIACONGRESS LETTER ON BEHALF OF DR. [read post]
20 Jun 2011, 1:31 pm by VMaryAbraham
The biggest organizational challenge has been that the rollout of these social business tools occured at the same time as Merck was merging with Schering Plough. [read post]
20 Jun 2011, 9:15 am by Paul Caron
At the end of its opinion, the Third Circuit blasted Schering-Plough's "chutzpah": Schering-Plough further complains that the IRS... [read post]
13 Jun 2011, 8:30 pm by Josh Wright
Panelists: Eric Goldman, Associate Professor of Law and Director of the High Tech Law Institute, Santa Clara University School of Law David Balto, Senior Fellow, Center for American Progress Frank Pasquale, Schering-Plough Professor in Health Care Regulation and Enforcement, Seton Hall University School of Law Joshua D. [read post]
8 Jun 2011, 5:12 pm by FDABlog HPM
Sharp conspired to falsify data for this study, so as to “remain in the clinical drug trial” and “receive monies from Schering/Plough. [read post]
30 May 2011, 4:55 am by Marie Louise
Egg World, LLC (Seattle Trademark Lawyer) Parties choose ACR, TTAB finds SOLARIN not confusingly similar to SOLARCAINE for sun/tanning products: Schering-Plough HealthCare Products, Inc. v. [read post]
24 May 2011, 2:09 pm by Jenna Greene
Court of Appeals for the Third Circuit, involves a settlement between Schering-Plough Corp., which owned a key patent (now expired) for the high blood pressure medication K-Dur 20, and generic drug makers Upsher Smith and ESI (formerly a division of Wyeth). [read post]
19 May 2011, 12:20 pm by Phil
This case is an antitrust challenge to an agreement settling patent litigation between defendant-appellee Schering-Plough Corp.2 ("Schering") and defendant-appellee Upsher-Smith Laboratories, Inc. [read post]
5 May 2011, 5:36 pm by Aaron Barkoff
Schering-Plough); the 2nd Circuit in 2006 (In re Tamoxifen); and the Federal Circuit in 2008 (In re Ciprofloxacin). [read post]
22 Apr 2011, 10:51 am by Zoe Tillman
Merck merged with Schering-Plough Corp. on Nov. 3, 2009, and, according to the complaint, had told PETA that they needed to prove ownership in Schering-Plough to be eligible. [read post]
28 Mar 2011, 1:57 pm by Tom Lamb
., Organon International (collectively, “Organon”), and Schering-Plough arising from Organon’s marketing and sale of NuvaRing, a combined hormonal contraceptive vaginal ring.... [read post]